BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 19224794)

  • 1. Xenon preconditioning: the role of prosurvival signaling, mitochondrial permeability transition and bioenergetics in rats.
    Mio Y; Shim YH; Richards E; Bosnjak ZJ; Pagel PS; Bienengraeber M
    Anesth Analg; 2009 Mar; 108(3):858-66. PubMed ID: 19224794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo.
    Pagel PS; Krolikowski JG; Shim YH; Venkatapuram S; Kersten JR; Weihrauch D; Warltier DC; Pratt PF
    Anesth Analg; 2007 Sep; 105(3):562-9. PubMed ID: 17717207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore.
    Vélez DE; Mestre-Cordero VE; Hermann R; Perego J; Harriet S; Fernandez-Pazos MLM; Mourglia J; Marina-Prendes MG
    J Physiol Biochem; 2020 Feb; 76(1):85-98. PubMed ID: 31916218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta.
    Feng J; Lucchinetti E; Ahuja P; Pasch T; Perriard JC; Zaugg M
    Anesthesiology; 2005 Nov; 103(5):987-95. PubMed ID: 16249673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
    Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
    Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
    Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A.
    Li J; Iorga A; Sharma S; Youn JY; Partow-Navid R; Umar S; Cai H; Rahman S; Eghbali M
    Anesthesiology; 2012 Oct; 117(4):836-46. PubMed ID: 22814384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
    Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
    Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore.
    Xi J; Wang H; Mueller RA; Norfleet EA; Xu Z
    Eur J Pharmacol; 2009 Feb; 604(1-3):111-6. PubMed ID: 19135050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-associated differences in activation of Akt/GSK-3beta signaling pathways and inhibition of mitochondrial permeability transition pore opening in the rat heart.
    Zhu J; Rebecchi MJ; Tan M; Glass PS; Brink PR; Liu L
    J Gerontol A Biol Sci Med Sci; 2010 Jun; 65(6):611-9. PubMed ID: 20427381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of autophagy restores the loss of sevoflurane cardiac preconditioning seen with prolonged ischemic insult.
    Shiomi M; Miyamae M; Takemura G; Kaneda K; Inamura Y; Onishi A; Koshinuma S; Momota Y; Minami T; Figueredo VM
    Eur J Pharmacol; 2014 Feb; 724():58-66. PubMed ID: 24374197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.
    Onishi A; Miyamae M; Kaneda K; Kotani J; Figueredo VM
    Eur J Pharmacol; 2012 Jan; 675(1-3):40-6. PubMed ID: 22166375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine 1-Phosphate Postconditioning Protects Against Myocardial Ischemia/reperfusion Injury in Rats via Mitochondrial Signaling and Akt-Gsk3β Phosphorylation.
    Fang R; Zhang LL; Zhang LZ; Li W; Li M; Wen K
    Arch Med Res; 2017 Feb; 48(2):147-155. PubMed ID: 28625317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation.
    Das S; Wong R; Rajapakse N; Murphy E; Steenbergen C
    Circ Res; 2008 Oct; 103(9):983-91. PubMed ID: 18802025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sevoflurane confers additive cardioprotection to ethanol preconditioning associated with enhanced phosphorylation of glycogen synthase kinase-3β and inhibition of mitochondrial permeability transition pore opening.
    Onishi A; Miyamae M; Inoue H; Kaneda K; Okusa C; Inamura Y; Shiomi M; Koshinuma S; Momota Y; Figueredo VM
    J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):916-24. PubMed ID: 23266287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase 2 protects against acute myocardial ischemia-reperfusion injury by modulating mitochondrial function and oxidative stress via the PI3K/Akt/GSK-3β RISK pathway.
    Sulaiman D; Li J; Devarajan A; Cunningham CM; Li M; Fishbein GA; Fogelman AM; Eghbali M; Reddy ST
    J Mol Cell Cardiol; 2019 Apr; 129():154-164. PubMed ID: 30802459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation.
    Clarke SJ; Khaliulin I; Das M; Parker JE; Heesom KJ; Halestrap AP
    Circ Res; 2008 May; 102(9):1082-90. PubMed ID: 18356542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
    Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B
    Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
    Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3beta.
    Chanoit G; Lee S; Xi J; Zhu M; McIntosh RA; Mueller RA; Norfleet EA; Xu Z
    Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1227-H1233. PubMed ID: 18660440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.